CTSOVSHAE• 7 Days (Normalized)
CTSO vs HAE (Cytosorbents Corporation vs Haemonetics Corporation)
Showing Closing Date Range from Sep 30 to Oct 7, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CTSO Performance $3.96
+1.54%
Cytosorbents Corporation
Normalized Baseline0.00%
HAE Performance $103.52
-1.69%
Haemonetics Corporation
Normalized Baseline0.00%
Alpha Spread Margin CTSO LEADS
+3.23 pts
CTSO outperforming by 3.23 percentage points
CTSOHAE
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CTSO HAE
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(5 dates)
| Date | CTSO Price | CTSO Gain (%) | HAE Price | HAE Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 06, 2026 | $3.96 | +1.54% | $103.52 | -1.69% | +3.23% |
| Oct 05, 2026 | $3.97 | +1.67% | $104.68 | -0.59% | +2.26% |
| Oct 02, 2026 | $4.05 | +3.85% | $104.68 | -0.59% | +4.44% |
| Oct 01, 2026 | $- | $104.37 | -0.88% | - | |
| Sep 30, 2026 | $3.90 | +0.00% | $105.30 | +0.00% | +0.00% |